Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP Amy Beth Vanduyn sold 640 shares of the company's stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $26.89, for a total value of $17,209.60. Following the completion of the sale, the senior vice president directly owned 129,180 shares of the company's stock, valued at approximately $3,473,650.20. This trade represents a 0.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Phreesia Trading Up 4.0%
Shares of PHR stock traded up $1.03 during mid-day trading on Monday, reaching $26.51. The stock had a trading volume of 597,110 shares, compared to its average volume of 456,444. The stock's 50-day moving average price is $26.50 and its two-hundred day moving average price is $26.41. The firm has a market capitalization of $1.58 billion, a PE ratio of -35.82 and a beta of 0.72. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53.
Phreesia (NYSE:PHR - Get Free Report) last announced its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. During the same quarter in the previous year, the firm posted ($0.05) EPS. The company's revenue for the quarter was up 14.5% compared to the same quarter last year. Equities analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Phreesia
A number of hedge funds have recently modified their holdings of the company. Johnson Financial Group Inc. lifted its position in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. Quarry LP lifted its position in Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares during the last quarter. KBC Group NV bought a new position in Phreesia during the first quarter valued at $74,000. Farther Finance Advisors LLC lifted its position in Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company's stock valued at $86,000 after purchasing an additional 3,000 shares during the last quarter. Finally, CWM LLC raised its stake in shares of Phreesia by 994.9% in the first quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after acquiring an additional 3,671 shares during the period. 92.10% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
PHR has been the topic of a number of research analyst reports. KeyCorp boosted their target price on Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Truist Financial increased their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Canaccord Genuity Group reduced their target price on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a research report on Thursday, May 29th. Citigroup restated a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. Finally, Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $32.27.
Check Out Our Latest Stock Analysis on PHR
About Phreesia
(
Get Free Report)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
